Literature DB >> 33817658

Radiation Segmentectomy for Small, Solitary Hepatocellular Carcinoma.

Matthew J Seager.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33817658      PMCID： PMC8011439          DOI： 10.1148/rycan.2021219006

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN： 2638-616X


× No keyword cloud information.
  2 in total

1.  Evaluation of Medium-Term Efficacy of Y90 Radiation Segmentectomy vs Percutaneous Microwave Ablation in Patients with Solitary Surgically Unresectable < 4 cm Hepatocellular Carcinoma: A Propensity Score Matched Study.

Authors:  Linzi Arndt; Alexander Villalobos; William Wagstaff; Bernard Cheng; Minzhi Xing; Robert M Ermentrout; Zachary Bercu; Mircea Cristescu; Anand Shah; Joel Wedd; Bill S Majdalany; Joseph F Magliocca; Marty T Sellers; Nima Kokabi
Journal:  Cardiovasc Intervent Radiol       Date:  2020-11-23       Impact factor: 2.740

2.  Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.

Authors:  Valérie Vilgrain; Helena Pereira; Eric Assenat; Boris Guiu; Alina Diana Ilonca; Georges-Philippe Pageaux; Annie Sibert; Mohamed Bouattour; Rachida Lebtahi; Wassim Allaham; Hélène Barraud; Valérie Laurent; Elodie Mathias; Jean-Pierre Bronowicki; Jean-Pierre Tasu; Rémy Perdrisot; Christine Silvain; René Gerolami; Olivier Mundler; Jean-Francois Seitz; Vincent Vidal; Christophe Aubé; Frédéric Oberti; Olivier Couturier; Isabelle Brenot-Rossi; Jean-Luc Raoul; Anthony Sarran; Charlotte Costentin; Emmanuel Itti; Alain Luciani; René Adam; Maïté Lewin; Didier Samuel; Maxime Ronot; Aurelia Dinut; Laurent Castera; Gilles Chatellier
Journal:  Lancet Oncol       Date:  2017-10-26       Impact factor: 41.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.